Mingzhou Guo

10.8k total citations
167 papers, 7.9k citations indexed

About

Mingzhou Guo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mingzhou Guo has authored 167 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Molecular Biology, 46 papers in Cancer Research and 23 papers in Oncology. Recurrent topics in Mingzhou Guo's work include Epigenetics and DNA Methylation (87 papers), Cancer-related gene regulation (65 papers) and RNA modifications and cancer (42 papers). Mingzhou Guo is often cited by papers focused on Epigenetics and DNA Methylation (87 papers), Cancer-related gene regulation (65 papers) and RNA modifications and cancer (42 papers). Mingzhou Guo collaborates with scholars based in China, United States and Philippines. Mingzhou Guo's co-authors include James G. Herman, Malcolm V. Brock, Shyamali C. Dharmage, Catherine Bennett, Manel Esteller, Douglas P. Clark, Yunsheng Yang, Bin Yang, Meiying Zhang and Stephen B. Baylin and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mingzhou Guo

162 papers receiving 7.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingzhou Guo China 49 5.7k 2.4k 1.3k 999 724 167 7.9k
Edward R. Sauter United States 44 3.2k 0.6× 1.8k 0.7× 1.6k 1.2× 635 0.6× 696 1.0× 198 7.0k
Stephen P. Finn Ireland 42 3.4k 0.6× 2.4k 1.0× 1.5k 1.1× 1.6k 1.6× 428 0.6× 189 6.1k
Mohammad Obaidul Hoque United States 52 5.9k 1.0× 2.0k 0.8× 1.8k 1.3× 1.7k 1.7× 1.3k 1.8× 133 8.3k
Bin Li China 50 6.6k 1.2× 3.2k 1.3× 2.1k 1.6× 1.6k 1.6× 755 1.0× 394 10.3k
Li‐Yan Xu China 44 4.5k 0.8× 2.0k 0.8× 1.4k 1.1× 1.0k 1.0× 984 1.4× 367 7.5k
Xiaoming Xie China 50 4.7k 0.8× 3.4k 1.4× 1.8k 1.3× 885 0.9× 440 0.6× 150 7.1k
Na Liu China 49 5.6k 1.0× 3.7k 1.5× 1.8k 1.4× 1.5k 1.5× 544 0.8× 319 9.1k
Jian Gu United States 55 6.6k 1.2× 3.0k 1.2× 2.0k 1.5× 1.5k 1.5× 1.4k 1.9× 333 10.5k
Yanyan Li China 40 4.0k 0.7× 1.6k 0.7× 1.7k 1.3× 671 0.7× 381 0.5× 265 6.5k
Aikou Okamoto Japan 36 4.4k 0.8× 3.1k 1.3× 1.9k 1.4× 770 0.8× 754 1.0× 267 8.0k

Countries citing papers authored by Mingzhou Guo

Since Specialization
Citations

This map shows the geographic impact of Mingzhou Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingzhou Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingzhou Guo more than expected).

Fields of papers citing papers by Mingzhou Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingzhou Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingzhou Guo. The network helps show where Mingzhou Guo may publish in the future.

Co-authorship network of co-authors of Mingzhou Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Mingzhou Guo. A scholar is included among the top collaborators of Mingzhou Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingzhou Guo. Mingzhou Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Xiaofeng, Ziyi Yan, Lichen Zhang, et al.. (2024). The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis. Oncogene. 43(7). 495–510. 16 indexed citations
3.
Zhang, Meiying, et al.. (2024). Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling. Cancer Biology & Therapy. 25(1). 2302924–2302924. 7 indexed citations
4.
Yuan, Hongyu, Zitong Zhao, Jing Xu, et al.. (2023). Hypoxia-induced TMTC3 expression in esophageal squamous cell carcinoma potentiates tumor angiogenesis through Rho GTPase/STAT3/VEGFA pathway. Journal of Experimental & Clinical Cancer Research. 42(1). 249–249. 14 indexed citations
5.
Xie, Dawei, Beibei Sun, Li-Wei Qu, et al.. (2023). High frequency of alternative splicing variants of the oncogene Focal Adhesion Kinase in neuroendocrine tumors of the pancreas and breast. Frontiers of Medicine. 17(5). 907–923. 5 indexed citations
6.
Zhang, Meiying, et al.. (2021). Intratumor Epigenetic Heterogeneity—A Panel Gene Methylation Study in Thyroid Cancer. Frontiers in Genetics. 12. 714071–714071. 6 indexed citations
7.
Ma, Yarui, Siyuan He, Aiai Gao, et al.. (2020). Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma. Clinical Epigenetics. 12(1). 25–25. 16 indexed citations
8.
Xie, Min, Xiansheng Liu, Xiaopei Cao, Mingzhou Guo, & Xiaochen Li. (2020). Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017. Respiratory Research. 21(1). 49–49. 123 indexed citations
9.
Gao, Aiai & Mingzhou Guo. (2020). Epigenetic based synthetic lethal strategies in human cancers. Biomarker Research. 8(1). 44–44. 27 indexed citations
10.
Yu, Tao, et al.. (2019). Alprostadil attenuates LPS-induced cardiomyocyte injury by inhibiting the Wnt5a/JNK/NF-κB pathway. Herz. 45(S1). 130–138. 12 indexed citations
11.
Gao, Dan, Tao He, Meiying Zhang, et al.. (2017). Methylation of DIRAS1 promotes colorectal cancer progression and may serve as a marker for poor prognosis. Clinical Epigenetics. 9(1). 50–50. 25 indexed citations
12.
Mei, Qian, Xiang Li, Kang Zhang, et al.. (2016). Genetic and Methylation-Induced Loss of miR-181a2/181b2 within chr9q33.3 Facilitates Tumor Growth of Cervical Cancer through the PIK3R3/Akt/FoxO Signaling Pathway. Clinical Cancer Research. 23(2). 575–586. 30 indexed citations
13.
Hou, Jian, Lian‐Di Liao, Yang‐Min Xie, et al.. (2013). DACT2 Is a Candidate Tumor Suppressor and Prognostic Marker in Esophageal Squamous Cell Carcinoma. Cancer Prevention Research. 6(8). 791–800. 22 indexed citations
14.
Li, Yangguang, Ti Wen, Lixin Li, et al.. (2013). Glycoproteomic analysis of tissues from patients with colon cancer using lectin microarrays and nanoLC-MS/MS. Molecular BioSystems. 9(7). 1877–1887. 33 indexed citations
15.
Guo, Mingzhou. (2013). Promoter Methylation-induced Expression Silencing of ZNF331 in Colorectal Cancer. 1 indexed citations
16.
Mei, Qian, Xiang Li, Yuanguang Meng, et al.. (2012). A Facile and Specific Assay for Quantifying MicroRNA by an Optimized RT-qPCR Approach. PLoS ONE. 7(10). e46890–e46890. 61 indexed citations
17.
Liu, Xuefeng, Dan Li, Weimin Zhang, Mingzhou Guo, & Qimin Zhan. (2012). Long non‐coding RNA gadd7 interacts with TDP‐43 and regulates Cdk6 mRNA decay. The EMBO Journal. 31(23). 4415–4427. 166 indexed citations
18.
19.
Ye, Ying, Michael A. McDevitt, Mingzhou Guo, et al.. (2009). Progressive Chromatin Repression and Promoter Methylation of CTNNA1 Associated with Advanced Myeloid Malignancies. Cancer Research. 69(21). 8482–8490. 35 indexed citations
20.
Yue, Wen, Sanja Đačić, Quanhong Sun, et al.. (2007). Frequent Inactivation of RAMP2, EFEMP1 and Dutt1 in Lung Cancer by Promoter Hypermethylation. Clinical Cancer Research. 13(15). 4336–4344. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward R. Sauter Breakdown of academic impact, for papers by Stephen P. Finn Breakdown of academic impact, for papers by Mohammad Obaidul Hoque Breakdown of academic impact, for papers by Bin Li Breakdown of academic impact, for papers by Li‐Yan Xu Breakdown of academic impact, for papers by Xiaoming Xie Breakdown of academic impact, for papers by Na Liu Breakdown of academic impact, for papers by Jian Gu Breakdown of academic impact, for papers by Yanyan Li Breakdown of academic impact, for papers by Aikou Okamoto
Rankless by CCL
2026